SCHEMBL15937337

SCHEMBL15937337

CC1(C)c2ccccc2N2c3ccccc3C(C)(C)c3cc(-c4cccc5c4oc4c(-c6cccc7c6oc6c(-c8cc9c%10c(c8)C(C)(C)c8ccccc8N%10c8ccccc8C9(C)C)cccc67)cccc45)cc1c32

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.34
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
PGR P06401 2/20 0.31
PRKDC P78527 3/20 0.30
CYP1A2 P05177 2/20 0.30
CYP2D6 P10635 2/20 0.30
PIK3CD O00329 2/20 0.30
PIK3CA P42336 2/20 0.30
PIK3CB P42338 2/20 0.30
PIK3CG P48736 2/20 0.30
PDE2A O00408 1/20 0.30
PIK3C2A O00443 1/20 0.30
PIK3R2 O00459 1/20 0.30
PIK3C2B O00750 1/20 0.30
BRD4 O60885 1/20 0.30
PDE5A O76074 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15937365 1.00 ALOX5 (0.34) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL15937342 0.99 ALOX5 (0.35) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL17717569 0.91 ALOX5 (0.30) ALOX5MAPTPGRALDH1A1
SCHEMBL15937289 0.85 ALOX5 (0.47) ALOX5KMT2AMEN1KDM4EPGR
SCHEMBL19367132 0.84 KMT2A (0.36) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL15678500 0.81 ALOX5 (0.37) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL15937411 0.81 ALOX5 (0.50) ALOX5KMT2AMEN1PGRPRKDC
SCHEMBL15937361 0.81 ALOX5 (0.35) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL15937285 0.80 ALOX5 (0.34) ALOX5KMT2AMEN1KDM4EMAPT
SCHEMBL15937288 0.80 ALOX5 (0.34) ALOX5KMT2AMEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE LMS CO., LTD. (KR) 2016-05-05 US disclosed
WO-2014119895-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE 주식회사 엘엠에스 (KR) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126476-A1 NOVEL COMPOUND, LIGHT EMITTING DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE ELAVL1, SUN2, PER2 ALOX5 640/4885KMT2A 2131/4885MEN1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.